Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational Results available

XIENCE Skypoint Large Vessel Post Approval Study

ClinicalTrials.gov ID: NCT05423379

Public ClinicalTrials.gov record NCT05423379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

SPIRIT XLV PAS is a prospective, single arm, multi-center, US and OUS post-approval observational study to evaluate the continued safety and effectiveness of the XIENCE Skypoint Large Vessel Everolimus Eluting Coronary Stent System (EECSS) Large Vessel (LV) sizes (diameter 4.5 mm and 5.0 mm) during commercial use in a real-world setting.

Study identification

NCT ID
NCT05423379
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
102 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 14, 2022 (Actual)
Primary completion
Nov 20, 2024 (Actual)
Completion
Aug 30, 2027 (Estimated)
Last update posted
Feb 24, 2026

2022 – 2027

United States locations

U.S. sites
13
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Arkansas Heart Hospital Little Rock Arkansas 72211 —
Memorial Hospital Jacksonville Jacksonville Florida 32216 —
Tallahassee Research Institute Tallahassee Florida 32308 —
Via Christi Regional Medical Center - St. Francis Campus Wichita Kansas 67226 —
Bryan Heart Lincoln Nebraska 68506 —
Lenox Hill Hospital New York New York 10075 —
Pinnacle Health System Wormleysburg Pennsylvania 17043 —
Anmed Health Anderson South Carolina 29621 —
Greenville Health System Greenville South Carolina 29605-5601 —
Hendrick Medical Center Abilene Texas 79601 —
Austin Heart Austin Texas 78756 —
The Heart Hospital Baylor Plano Plano Texas 75074 —
Shannon Clinic San Angelo Texas 76903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05423379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05423379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →